HLB Co., Ltd. (028300.KQ)
KRW 70500.0
(-1.26%)
KRW 70500.0
(-1.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.42 Billion KRW | -7.47% |
| 2022 | 12.34 Billion KRW | -10.62% |
| 2021 | 13.81 Billion KRW | 183.36% |
| 2020 | 4.87 Billion KRW | -0.9% |
| 2019 | 4.91 Billion KRW | 27.41% |
| 2018 | 3.86 Billion KRW | -6.82% |
| 2017 | 4.14 Billion KRW | 7.48% |
| 2016 | 3.85 Billion KRW | -27.35% |
| 2015 | 5.3 Billion KRW | -30.86% |
| 2014 | 7.67 Billion KRW | 69.0% |
| 2013 | 4.54 Billion KRW | -39.98% |
| 2012 | 7.56 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 12.34 Billion KRW | 8.13% |
| 2024 Q2 | 14.08 Billion KRW | 14.04% |
| 2023 Q3 | 7 Billion KRW | -19.73% |
| 2023 Q2 | 8.72 Billion KRW | 9.23% |
| 2023 FY | 11.42 Billion KRW | -7.47% |
| 2023 Q1 | 7.98 Billion KRW | -35.3% |
| 2023 Q4 | 11.42 Billion KRW | 63.11% |
| 2022 Q4 | 12.34 Billion KRW | -10.86% |
| 2022 Q3 | 13.84 Billion KRW | -20.3% |
| 2022 Q2 | 17.37 Billion KRW | 8.89% |
| 2022 Q1 | 15.95 Billion KRW | 15.54% |
| 2022 FY | 12.34 Billion KRW | -10.62% |
| 2021 Q4 | 13.81 Billion KRW | 61.23% |
| 2021 Q2 | 6.75 Billion KRW | 24.05% |
| 2021 FY | 13.81 Billion KRW | 183.36% |
| 2021 Q1 | 5.44 Billion KRW | 11.68% |
| 2021 Q3 | 8.56 Billion KRW | 26.86% |
| 2020 Q1 | 5.92 Billion KRW | 20.54% |
| 2020 FY | 4.87 Billion KRW | -0.9% |
| 2020 Q2 | 8.21 Billion KRW | 38.5% |
| 2020 Q3 | 14.88 Billion KRW | 81.23% |
| 2020 Q4 | 4.87 Billion KRW | -67.25% |
| 2019 Q1 | 4.8 Billion KRW | 24.55% |
| 2019 Q2 | 6.09 Billion KRW | 26.72% |
| 2019 FY | 4.91 Billion KRW | 27.41% |
| 2019 Q4 | 4.91 Billion KRW | -28.03% |
| 2019 Q3 | 6.83 Billion KRW | 12.17% |
| 2018 Q1 | 6.07 Billion KRW | 46.58% |
| 2018 Q4 | 3.86 Billion KRW | -44.63% |
| 2018 Q3 | 6.97 Billion KRW | 25.57% |
| 2018 Q2 | 5.55 Billion KRW | -8.57% |
| 2018 FY | 3.86 Billion KRW | -6.82% |
| 2017 Q4 | 4.14 Billion KRW | -21.42% |
| 2017 FY | 4.14 Billion KRW | 7.48% |
| 2017 Q1 | 4.65 Billion KRW | 20.87% |
| 2017 Q2 | 4.68 Billion KRW | 0.58% |
| 2017 Q3 | 5.27 Billion KRW | 12.49% |
| 2016 Q3 | 4.71 Billion KRW | -11.59% |
| 2016 FY | 3.85 Billion KRW | -27.35% |
| 2016 Q4 | 3.85 Billion KRW | -18.25% |
| 2016 Q2 | 5.33 Billion KRW | -3.07% |
| 2016 Q1 | 5.5 Billion KRW | 3.7% |
| 2015 Q1 | 8.11 Billion KRW | 5.79% |
| 2015 Q4 | 5.3 Billion KRW | -23.75% |
| 2015 FY | 5.3 Billion KRW | -30.86% |
| 2015 Q2 | 7.13 Billion KRW | -12.16% |
| 2015 Q3 | 6.95 Billion KRW | -2.41% |
| 2014 Q4 | 7.67 Billion KRW | -6.78% |
| 2014 Q3 | 8.23 Billion KRW | 58.34% |
| 2014 Q2 | 5.19 Billion KRW | 5.45% |
| 2014 Q1 | 4.92 Billion KRW | 8.57% |
| 2014 FY | 7.67 Billion KRW | 69.0% |
| 2013 Q4 | 4.54 Billion KRW | 13.82% |
| 2013 FY | 4.54 Billion KRW | -39.98% |
| 2013 Q1 | 10.46 Billion KRW | 38.34% |
| 2013 Q3 | 3.98 Billion KRW | -50.35% |
| 2013 Q2 | 8.03 Billion KRW | -23.23% |
| 2012 Q4 | 7.56 Billion KRW | 0.0% |
| 2012 FY | 7.56 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| iNtRON Biotechnology, Inc. | 1.01 Billion KRW | -1029.611% |
| BINEX Co., Ltd. | 28.26 Billion KRW | 59.586% |
| Bioneer Corporation | 41.35 Billion KRW | 72.381% |
| Anterogen.Co.,Ltd. | 1.91 Billion KRW | -497.829% |
| MEDIPOST Co., Ltd. | 14.51 Billion KRW | 21.322% |
| CrystalGenomics, Inc. | 1.55 Billion USD | -634.603% |
| Helixmith Co., Ltd | 914.11 Million KRW | -1149.466% |
| Chabiotech Co.,Ltd. | 34.11 Billion KRW | 66.522% |
| Medy-Tox Inc. | 59.61 Billion KRW | 80.842% |
| Peptron, Inc. | 172.18 Million KRW | -6533.209% |
| Amicogen, Inc. | 46.83 Billion KRW | 75.615% |
| Genexine, Inc. | 3.8 Billion KRW | -200.02% |
| HLB Therapeutics Co.,Ltd. | 5.33 Billion KRW | -114.054% |
| LegoChem Biosciences, Inc. | 196.83 Million KRW | -5702.618% |
| ALTEOGEN Inc. | 1.06 Billion KRW | -969.074% |
| PharmaResearch Co., Ltd. | 50.23 Billion KRW | 77.263% |
| SillaJen, Inc. | 1.21 Billion KRW | -841.886% |
| JETEMA, Co., Ltd. | 12.74 Billion KRW | 10.355% |
| OliX Pharmaceuticals,Inc | 468.4 Million KRW | -2338.369% |
| Genomictree Inc. | 496.53 Million KRW | -2200.267% |
| MedPacto, Inc. | 620.00 KRW | -1842185058.871% |
| D&D Pharmatech | 3.45 Billion KRW | -231.038% |
| EASY BIO,Inc. | 25.93 Billion KRW | 55.967% |
| GI Innovation, Inc. | - KRW | -Infinity% |